BBlogFlow

Projected prevalence of hypertension and untreated/uncontrolled hypertension in Japan through 2040 - Nature

·32m ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : Content cover image

IntroductionHypertension is a major global health concern and a leading cause of morbidity and mortality [1]. It is estimated that more than 19 million annual deaths are attributed to cardiovascular disease (CVD) worldwide [2]. In Japan, high blood pressure (BP) has been consistently identified as a strong risk factor for the national burden of CVD, in terms of notable incidence, mortality, direct/indirect healthcare costs, and quality-adjusted life years (QALYs) associated with this condition [3, 4]. Although age-specific mean BP declined in Japan over recent decades [5], hypertension remains a critical public health issue, particularly because of the rapid aging population. The proportion of individuals aged ≥65 years is projected to reach approximately 35% by 2040 in Japan [6], highlighting a potentially higher future burden of hypertension in this country. While the prevalence of hypertension increases with age, population aging may offset the benefits of declining BP levels in each age group. As a result, the future burden of hypertension in Japan remains uncertain.

This article is an excerpt. To read the full content, visit the original source. Nature

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Neuropathic Pain-Like Features in Patients With Rheumatoid Arthritis and Spondyloarthritis Receiving Targeted Therapies: Prevalence and Associated Factors - Cureus

Persistent pain despite targeted therapy remains a major challenge in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA), and neuropathic pain-like features may contribute to this residual pain. We conducted a cross-sectional study including 155 patients receiving biologic or targeted synthetic disease-modifying antirheumatic drugs (bDMARDs or tsDMARDs; 78 RA and 77 SpA) to determine the prevalence of neuropathic pain-like features and identify associated clinical factors. Neuropathic pain-like features were screened using the Douleur Neuropathique 4 (DN4) and painDETECT questionnaires. Univariable logistic regression analyses were performed separately for each disease group, followed by parsimonious multivariable models including functional impairment, disease activity, and current pain intensity. Neuropathic pain-like features (DN4 ≥4) were identified in 19 (24.4%) patients with RA and 21 (27.3%) patients with SpA, with no statistically significant between-group difference (p = 0.679). Although median painDETECT scores were significantly higher in SpA, the distribution of painDETECT categories did not differ significantly between the two groups. In univariable an

Cureus·

Forecasting air drag with deep learning helps predict when uncontrolled satellites and rocket stages fall to Earth - Phys.org

On May 10, 2025, a spacecraft built in the Soviet Union to land on Venus came home. Launched in 1972, Cosmos-482 was stranded by a failed upper stage of its rocket and circled Earth for 53 years. In its last days, several space agencies and research groups forecasted when it would fall, and therefore where. Roscosmos later reported that it came down in the Indian Ocean, west of Jakarta.

Phys.org·

Fatty liver disease is actually five different conditions, scientists discover - Science Daily

A common liver disease affecting nearly 30% of adults worldwide is far more complex than previously understood. Researchers at Mayo Clinic have identified five biologically distinct forms of the condition, each associated with different risks of serious health complications, including heart disease, liver failure, cancer, and the need for a liver transplant. The findings, published in Nature Communications, come from a collaboration between Mayo Clinic and Virginia Tech. Scientists discovered that metabolic dysfunction-associated steatotic liver disease, or MASLD, can develop through several different biological pathways. Some are closely connected to obesity and diabetes, while others appear to be driven by inherited genetic differences.

Science Daily·